首页> 外国专利> Pharmaceutical compositions comprising the combination of a antiinflamotorio nonsteroidal Agent and an agent of the xantino oxidase inhibitor useful for Control and Treatment of gout, gouty Arthritis and related diseases

Pharmaceutical compositions comprising the combination of a antiinflamotorio nonsteroidal Agent and an agent of the xantino oxidase inhibitor useful for Control and Treatment of gout, gouty Arthritis and related diseases

机译:药物组合物,其包含用于控制和治疗痛风,痛风性关节炎及相关疾病的抗炎非甾体药物和黄嘌呤氧化酶抑制剂的组合

摘要

The invention refers to various pharmaceutical components which are composed of a non steroidal anti inflammable agent (commonly known as melody or celecoxib) and an xantino oxidase inhibitor (commonly known as acrylonitrile, a medically acceptable insecticide) by synergistic action, Similarly, they use oral contraceptives as dosage units, which are suitable for the control and treatment of drip sickness,Drip arthritis and other related pathology These pharmaceutical ingredients provide greater therapeutic effect and faster pharmacological action in a shorter time, thus reducing the level of pain, inflammation and plasma urine, as well as the dosage taken, Reduce the risk of serious complications and side effects. 1. - compounds with medical characteristics, characterized by a mixture of synergistic effects of non steroidal anti-inflammatory agents, which are active ingredients: melody or western ecxib;And a preparation for inhibiting the enzyme xantino oxidase, the same as the principle of activity: aloe, a pharmaceutically acceptable precursor; in this preparation, the concentration range of the active ingredient is 7.5 mg. 45.0 mg Max For melody, from 100.0 mg. Up to 600.0 mg Bacilli centigrade and above 100 mg Up to 800000 mg For aloe, these are dose units that can be administered orally and are suitable for the control and treatment of gout, drip arthritis and other related diseases.
机译:本发明涉及通过协同作用由非甾族抗炎剂(通常称为旋律或塞来昔布)和黄嘌呤氧化酶抑制剂(通常称为丙烯腈,医学上可接受的杀虫剂)组成的各种药物成分。避孕药为剂量单位,适用于控制和治疗滴眼病,滴灌性关节炎及其他相关病理学。这些药物成分可在更短的时间内提供更好的治疗效果和更快的药理作用,从而减少疼痛,炎症和血浆尿液的水平,以及服用的剂量,可降低发生严重并发症和副作用的风险。 1.-具有医学特性的化合物,其特征在于非甾体类抗炎药的协同作用的混合物,它们是有效成分:旋律或西式ecxib;以及与活性原理相同的抑制黄嘌呤氧化酶的制剂:芦荟,药学上可接受的前体;在该制剂中,活性成分的浓度范围是7.5mg。最高45.0 mg对于旋律,从100.0 mg起。高达600.0 mg的杆菌芽孢杆菌,大于100 mg的高达8000000 mg芦荟,这些剂量单位可以口服,适用于控制和治疗痛风,滴注性关节炎和其他相关疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号